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Summary
We performed genetic mapping studies of an 11-gen-
eration pedigree with an autosomal dominant, juvenile-
onset motor-systems disease. The disorder is character-
ized by slow progression, distal limb amyotrophy, and
pyramidal tract signs associated with severe loss of mo-
tor neurons in the brain stem and spinal cord. The gene
for this disorder, classified as a form of juvenile amy-
otrophic lateral sclerosis (ALS), is designated “ALS4.”
We performed a genomewide search and detected strong
evidence for linkage of the ALS4 locus to markers from
chromosome 9q34. The highest LOD score (Z) was ob-
tained with D9S1847 ( , recombination fractionZ  18.8
of .00). An analysis of recombinant events identified
D9S1831 and D9S164 as flanking markers, on chro-
mosome 9q34, that define an ∼5-cM interval that har-
bors the ALS4 gene. These results extend the degree of
heterogeneity within familial ALS syndromes, and they
implicate a gene on chromosome 9q34 as critical for
motor-neuron function.
Introduction
Amyotrophic lateral sclerosis (ALS [MIM 105400]), also
known as “Lou Gehrig disease,” denotes a widely rec-
ognized, heterogeneous group of progressive neurolog-
ical disorders associated with degeneration of motor
neurons in the cerebral cortex, brain stem, and spinal
cord (Williams and Windebank 1991). Although ALS is
most commonly encountered as a sporadic condition
that is presumed not to have been inherited, ∼5%–10%
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of patients have similarly affected relatives; this indicates
that genetic factors play an important role in the de-
velopment of some motor-neuron disorders (Strong et
al. 1991). Inherited forms of ALS are classified as “fa-
milial ALS” (Mulder et al. 1986). The clinical pheno-
types of sporadic and familial ALS can be virtually in-
distinguishable; however, pathological studies in
pedigrees with familial ALS have documented more ex-
tensive, subclinical involvement of the nervous system,
including degeneration of the posterior columns,
Clarke’s column, and spinocerebellar tracts (Engel et al.
1957; Brownell et al. 1970; Tanaka et al. 1984).
The gene for an autosomal dominant form of familial
ALS (ALS1) maps to chromosome 21q22.1-22.2 (Sid-
dique et al. 1991) and is associated with mutations in
the copper-zinc superoxide dismutase (SOD-1) gene (Ro-
sen et al. 1993). ALS1 patients typically have an adult-
onset illness that progresses rapidly and leads to death,
from respiratory collapse and pneumonia, within 3–5
years of onset, although ALS1 families in which disease
progression has exceeded 10 years have been described
(Williams and Windebank 1991).
Childhood- or adolescent-onset forms of familial ALS
carry the designation “juvenile ALS.” Ben Hamida et al.
(1990) described 17 Tunisian kindreds with various
forms of early-onset ALS. The mean age at onset was
12 years, and illness progressed slowly. Patients with
juvenile ALS may have normal life spans, but neuro-
muscular impairment is typically severe. Autosomal re-
cessive forms of juvenile ALS map to either chromosome
2q33-35, designated “ALS2” (Hentati et al. 1994), or
chromosome 15q12-21, designated “ALS5” (Hentati et
al. 1997). The molecular bases of ALS2 and ALS5 are
unknown. Although ALS1 and ALS2 share the clinical
feature of motor-neuron degeneration, they are clinically
and genetically distinct disorders. The identification of
pedigrees with adult-onset, autosomal dominant ALS
that is neither linked to chromosome 21 nor associated
with mutations in SOD-1 suggests the existence of ad-
ditional loci for familial ALS; this form has been des-
ignated “ALS3” (Siddique et al. 1991).
Here, we report analysis of a large pedigree with a
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Figure 1 Pedigree K7000, which segregates an autosomal dominant form of juvenile ALS. Females are indicated by circles and males by
squares. Blackened figures denote affected individuals, and slashed figures denote deceased individuals. Genotypes for chromosome 9 markers
were determined for all living persons shown. Haplotypes for boxed portions of the pedigree are presented in figure 3A and B.
slowly progressive, autosomal dominant form of juvenile
ALS. The gene for this disorder, designated “ALS4,”
maps to chromosome 9q34 and is genetically distinct
from previously mapped familial ALS syndromes.
Subjects and Methods
Description of Pedigree
We studied an 11-generation pedigree (K7000; fig. 1)
that was originally described in 1964 (Myrianthopoulos
et al. 1964). Ancestors of this kindred were traced to
17th-century England, and the disorder was documented
in eight generations, including 52 affected persons living
in southern Maryland and nearby states. Autosomal
dominant inheritance was confirmed by the presence of
male-to-male transmission. In the present study, diag-
nosis of early-onset selective upper– and lower–motor-
neuron involvement was established by the patient’s his-
tory, the clinical findings, and the results of electrophy-
siological tests. Affected persons typically manifested
symptoms in the 2d decade of life (mean age at onset,
17 years). They initially had difficulty walking; this was
followed by weakness and wasting of small muscles of
the hands and distal lower extremities. By the 4th or 5th
decade, affected persons had significant proximal weak-
ness and were frequently wheelchair-bound, and by the
6th decade, they had lost useful hand function. Bulbar
muscles were not symptomatically involved. Neurolog-
ical examinations were performed by four neurologists
(D.R.C., J.W.G., B.A.R., and M.S.). Forty-nine affected
and 34 at-risk individuals were evaluated by means of
a standardized examination that assessed mental, cranial
nerve, sensory, motor, deep-tendon reflex, and cerebellar
status. Intelligence was normal. There was pathological
hyperreflexia in 86% of affected individuals, and 17%
had extensor plantar responses. In many affected indi-
viduals, weakness of the toe and foot extensor muscles
prevented interpretation of the plantar response. De-
tailed sensory examinations, including tests for both
large- and small-fiber–type sensory functions, were per-
formed in 49 subjects: 44 had normal sensory
examination results, and 5 older individuals (mean age,
51 years) had slight elevation of the vibratory threshold
in the feet. Six subjects had normal skin biopsies, for
quantitation of intraepidermal sensory nerve fibers, in
accordance with methods described elsewhere (McCar-
thy et al. 1995).
Electrophysiological Studies
Sensory- and motor-nerve–conduction studies of the
upper and lower extremities were performed, in five
moderately to severely affected patients, according to
standard methods (Kimura 1989). Sensory responses
were normal, and motor-nerve–conduction studies
showed absent or reduced-amplitude compound muscle-
action potentials in all five subjects, with normal motor-
nerve–conduction velocities. Needle electromyography
showed evidence of chronic partial denervation; distal
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muscles were more abnormal than were proximal
muscles.
Neuropathological Description
Pathological examination of the brain, spinal cord,
and nerve roots was performed on an 88-year-old
woman (individual VII-10 ) who died of respiratory fail-
ure after an ischemic stroke. Gross inspection of the
spinal cord demonstrated atrophy of the ventral and
dorsal roots. Microscopic evaluation of the spinal cord
parenchyma disclosed loss of anterior horn cells and
pallor of the dorsal columns. The severity of anterior
horn-cell loss varied from section to section but was
greater at lumbosacral levels, where ∼50% of the an-
terior horn cells were missing. Many remaining neurons
showed chromatolysis. Inspection of the ventral and dor-
sal roots revealed numerous axonal swellings, some of
which stained positive for phosphorylated neurofila-
ments. Microscopic evaluation of the brain disclosed nu-
merous axonal spheroids in the dentate nucleus and nu-
cleus gracilis, and rare ubiquitin-positive cytoplasmic
inclusions were found in neurons of the inferior olivary
nucleus. In this patient, no definite neuropathological
changes were seen in upper motor neurons or their ax-
ons. Prominent axonal swellings were noted in the in-
tracranial portions of the third and fourth cranial nerves.
Genetic Markers
Under a protocol of informed consent, blood samples
were obtained, by venipuncture, for isolation of DNA
and establishment of permanent cell lines, by standard
methods. One hundred fifty PCR-based markers that
identified loci spaced at ∼10-cM intervals (version 6,
Research Genetics) were used to search the genome for
linkage (Weber and May 1989). Genetic maps and pri-
mer sequences for markers were obtained from internet
sources, including the Genome Database (Gyapay et al.
1994) and the Cooperative Human Linkage Center
(Murray et al. 1994). Methods for obtaining genotypes
have been described elsewhere (Pellegrino et al. 1996).
One hundred seven individuals were genotyped, includ-
ing 52 affected and 37 at-risk individuals.
Linkage Analysis
Pairwise LOD scores (Z) and multipoint location
scores were calculated, between marker loci and ALS4,
by use of the computer program LINKAGE, version 5.1
(Lathrop et al. 1985). Zscores were calculated under a
model of autosomal dominant inheritance. Penetrance
of the ALS4 gene was taken as .99, and equiprobable
male and female recombination fractions (vs) were as-
sumed. The frequency of the mutant allele was taken as
.0001. Equal gene frequencies were taken for marker
alleles (use of marker allele frequencies estimated from
a pool of 30 unrelated individuals had no significant
effect on the LOD-score calculations). Unaffected at-risk
individuals, aged !21 years, and individuals for whom
neurological findings were equivocal were typed “un-
known” for the trait phenotype; thus, these individuals
provided marker information only. For multilocus anal-
ysis, location of the ALS4 gene was tested against a fixed
map of seven markers in chromosome 9q34 (D9S1821,
D9S260, D9S1831, D9S1847, D9S1830, D9S164, and
D9S1818), and genetic distances were taken from pub-
lished sources (Gyapay et al. 1994; Murray et al. 1994;
Dib et al. 1996). Haldane’s equation was used to convert
vs to genetic distances (Ott 1985). Calculations were
carried out on a VAX 6520 computer.
Results
Linkage to regions known to harbor the loci for pre-
viously mapped motor-neuron syndromes was initially
excluded. ALS4 does not map to the regions of ALS1
or ALS2. Linkage to D21S223 (which is closely linked
to ALS1) was excluded ( , ). MarkerZ  2.0 v  .1
D2S72 was tested for linkage to ALS2, on chromosome
2q (Hentati et al. 1994), and linkage was excluded
( , ). Markers from the spinal muscular-Z  2.0 v  .20
atrophy (SMA)–gene region, on chromosome 5q11.2-
13.3, were tested, including D5S435 (which maps within
1 cM of the SMA locus) (Brzustowicz et al. 1990; Wirth
et al. 1994), and no evidence for linkage was found
( , ). Furthermore, deletion of exons 7Z  2.15 v  .1
and 8 of the survival motor-neuron (SMN) gene, which
is associated with ∼90% of SMA cases (Lefebvre et al.
1995), was not detected in an affected person from ped-
igree K7000 (P Bingham, personal communication).
Linkage to the region of an autosomal dominant form
of SMA, on chromosome 7p (Christodoulou et al. 1995),
was tested and excluded ( , ) withZ  2.0 v  .15
marker D7S795. Therefore, the neurological disorder
segregating in pedigree K7000 is genetically distinct
from these previously mapped motor-neuron syndromes,
including forms of ALS.
To map ALS4, we performed a genomewide search,
testing 150 PCR-based DNA markers (data available on
request). Linkage was initially detected with markers
D9S158 ( , ) and D9S915 (Z  6.12 v  .059 Z max max
, ), which map to distal chromosome 9q344.82 v  .038
(Hudson et al. 1995). Additional markers in this region
were tested, to refine the map position of ALS4 and to
identify flanking markers (listed in table 1). The highest
Z score was obtained with marker D9S1847 (Z 
, ). Haplotypes were constructed and a18.84 v  .00
multilocus analysis, based on marker orders derived
from published maps of chromosome 9 (Gyapay et al.
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Table 1
Z Scores at Various Recombination Fractions, for Markers on Chromosome 9q, in Pedigree
K7000
MARKER
Z SCORE AT v 
Zmax v.00 .01 .05 .1 .2 .3 .4
D9S1821 9.28 2.22 1.73 2.96 3.14 2.32 1.12 3.25 .157
D9S260 11.82 2.50 1.01 2.04 2.17 1.54 .72 2.28 .155
D9S1831 17.82 .65 4.38 5.62 5.11 3.33 1.33 5.71 .124
D9S1863 1.83 6.08 6.67 6.25 4.69 2.90 1.22 6.67 .045
D9S1847 18.84 18.51 17.13 15.33 11.51 7.53 3.52 18.84 .000
D9S1830 11.03 11.07 10.46 9.34 6.84 4.29 1.88 11.08 .006
D9S164 4.69 9.04 9.74 9.24 7.24 4.75 2.12 9.74 .046
D9S1818 2.26 5.13 6.55 6.44 4.97 2.99 1.09 6.60 .065
9qter
Figure 2 Multilocus analysis, with the ALS4 gene, against a fixed
genetic map of linked markers. Order of markers and distances are
taken from published sources (Gyapay et al. 1994; Murray et al. 1994;
Dib et al. 1996). The highest probability for location of ALS4 is in
the region of D9S1847 and D9S1830.
1994; Murray et al. 1994; Dib et al. 1996), was per-
formed. The results of the multilocus analysis are shown
in figure 2; these results provide additional support for
localization of ALS4 to chromosome 9q34. The highest
probability for a location of ALS4 occurred in the region
of markers D9S1847 and D9S1830 (peak location score
120.0). An analysis of crossovers seen in affected indi-
viduals, between ALS4 and markers within this region,
was used to define a candidate interval for ALS4 (fig.
3A and B). Individual VIII-17 is an affected male in
whom a crossover occurred, between D9S1831 and
D9S1847 (fig. 3A). For affected individual IX-11, gen-
otypes from deceased parents, needed to determine
phase, are unavailable; however, there is an apparent
crossover between D9S1830 and D9S164 (fig. 3B).
These results suggest that ALS4 is telomeric to D9S1831
and centromeric to D9S164, defining an ∼5-cM interval
within chromosome 9q34 (see fig. 4).
Discussion
The designation “ALS” refers to a group of progres-
sive disorders that affect upper and lower motor neu-
rons, without sensory changes, and that lack other
known causes (Brooks 1994). Although ALS is fre-
quently associated with rapid progression and early
death, a diagnosis of ALS does not require any specific
duration of disease (provided there is progression), and
patients may survive for many years. Given the clinical
pattern of progressive, selective motor-system dysfunc-
tion, with pyramidal tract signs, affected members of
pedigree K7000 conform to this recognized clinical ALS
phenotype.
The results of the present analysis support the local-
ization of a gene, on chromosome 9q34, for this auto-
somal dominant form of juvenile ALS. These findings
extend the degree of genetic heterogeneity within juve-
nile ALS and other phenotypically similar disorders that
are characterized by onset during adolescence and pre-
dominant motor-systems deterioration. More impor-
tantly, this observation implicates the existence, on chro-
mosome 9, of yet another gene that is critical for the
normal function of motor neurons.
It can be speculated that the gene for ALS4 may in-
volve an abnormality in a neuron-specific component,
or, as proposed for SOD-1 in ALS1, that it could result
from mutations in a more widely or even ubiquitously
expressed protein that has a function that is crucial to
motor neurons (Brown 1995). The discovery of SOD-1
mutations that lead to ALS has provided many novel
insights into the biology of motor neurons. It remains
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Figure 3 Recombinant events localize the ALS4 gene on chromosome 9q34 and define a 5-cM interval. Two portions of pedigree K7000
(boxed in fig. 1) that contain crossovers, within chromosome 9q34, that localize ALS4 between markers D9S1831 and D9S164 are shown. A,
For individual VIII-17, a crossover occurred between D9S1831 and D9S1847. B, For individual IX-11, a crossover occurred between D9S1830
and D9S164.
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Figure 4 Ideogram of chromosome 9 that shows the map place-
ment of markers in band 9q34 and the interval containing the ALS4
locus. Genetic distances are given in centimorgans.
unclear, however, how mutations in SOD-1 actually lead
to progressive motor-neuron loss. It is not certain that
all familial-ALS mutations cause dysfunction in proteins
involved in free-radical scavenging. There is mounting
evidence that cellular excitotoxicity may play a promi-
nent role in the pathogenesis of sporadic ALS, and it
would be reasonable to expect that mutations in this
pathway might also lead to inherited motor-neuron dys-
function (Bristol and Rothstein 1996). Clearly, given the
similarities and differences between ALS4 and other
forms of inherited ALS, identification of the underlying
defect will provide important new clues to the under-
standing of possible mechanisms that lead to motor-neu-
ron dysfunction and death. Mapping and the eventual
identification of the ALS4 gene are critical steps toward
development of additional animal models for investi-
gation of motor-neuron degeneration.
The clinical and neurophysiological phenotype of se-
lective motor impairment seen in individuals from ped-
igree K7000 predicted that pathological disturbances
might be limited to the motor systems. Interestingly, neu-
ropathological evaluation of the brain and spinal cord
of an 88-year-old woman in pedigree K7000 disclosed
evidence of more widespread damage to the nervous
system. In addition to motor-neuron degeneration, ax-
onal swellings and reactive astrocytes were present
throughout the spinal cord gray matter, particularly the
dorsal root exit zones. These multisystem neuropatho-
logical findings observed in ALS4 are consistent with the
spectrum of non–motor-system changes recognized in
other forms of autosomal dominant, adult-onset, more
rapidly progressive familial ALS (Engel et al. 1957; Hir-
ano et al. 1967). Therefore, clinical designation of the
pedigree-K7000 neurological disorder as a juvenile ALS
syndrome is warranted. Clearly, in familial ALS, other
regions of the nervous system may be affected at a neu-
ropathological level, despite a clinical phenotype that
suggests only motor-neuron dysfunction. As mentioned
above, a selective vulnerability of motor neurons to the
consequences of a mutant gene might explain this ob-
servation. Nevertheless, the discrepancy between clinical
motor-neuron phenotype and observed neuropatholog-
ical features in familial ALS merits further investigation,
and identification of a gene for ALS4 may provide insight
into this interesting paradox.
In addition to ALS4, two other neurological disorders
are known to map to the region of chromosome 9q34.
These are tuberous sclerosis 1 (TSC1), the gene region
for which overlaps that of the ALS4 locus (van Slegten-
horst et al. 1997), and torsion dystonia (TYD1), the gene
for which is located centromeric to ALS4 (Pericak-Vance
et al. 1995). Several plausible ALS4 candidate genes that
map to this region of chromosome 9 include the death-
associated protein kinase (DAPK1) gene (Feinstein et al.
1995), a calcium channel (L-type, a1 polypeptide;
CACNL1A5) (Dirong et al. 1995), the N-methyl-D-as-
partate receptor (GRIN-1) (Brett et al. 1994), and a ki-
nesin-related gene (ATSV) (Furlong et al. 1996). ATSV
is an especially attractive candidate, given the observa-
tion of axonal swelling in ALS4, which might suggest
impaired axonal transport as a primary pathogenetic
mechanism that leads to dysfunction of motor neurons
and other cell types.
The clinical and genetic nosology of inherited disor-
ders that affect motor systems is complex and evolving.
In particular, the overlap of phenotypic features found
in familial motor-neuron diseases, hereditary spastic par-
aplegias, and hereditary peripheral polyneuropathies
(e.g., Charcot-Marie-Tooth neuropathy; CMT) has im-
peded classification and recognition of juvenile ALS (Ben
Hamida et al. 1990). For example, the pedigree-K7000
disorder was initially reported as a variant of CMT, de-
spite the presence of upper–motor-neuron dysfunction
and the absence of sensory-nerve impairment (Myrian-
thopoulos et al. 1964). Similarly, numerous other reports
have documented autosomal dominant syndromes of
progressive limb amyotrophy, hyperactive deep-tendon
reflexes, extensor plantar responses, and minimal or no
sensory-nerve impairment, including peroneal muscular
atrophy with pyramidal features (CMT type V; Harding
and Thomas 1984), familial spastic paraplegia with
amyotrophy of the hands (Silver syndrome; Silver 1966),
and others (Refsum and Skillicorn 1954; Cross and
McKusick 1967; Lander et al. 1976; Van Gent et al.
1985). Regardless of the diagnostic terminology for ped-
igree K7000, the results of this analysis show that an
important gene for motor-neuron function maps to chro-
mosome 9q34. As a clinical entity, this mapped form of
autosomal dominant juvenile ALS in pedigree K7000
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may be an underrecognized disorder. It will be crucial
to test other kindreds that have motor-neuron disorders,
with phenotypes similar to those seen in pedigree K7000,
for linkage to the ALS4 region on chromosome 9q34.
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